| Recruiting | 1 | 500 | Europe, RoW | CK-301 (cosibelimab) | Checkpoint Therapeutics, Inc., Novotech (Australia) Pty Limited | Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced, Head and Neck Cancer, Melanoma, Merkel Cell Carcinoma, Renal Cell Carcinoma, Urothelial Carcinoma, Classical Hodgkin Lymphoma, Cutaneous Squamous Cell Carcinoma, Non Hodgkin Lymphoma, Endometrial Cancer | 11/21 | 12/24 | | |